These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16598153)

  • 1. Botulinum neurotoxins: perspective on their existence and as polyproteins harboring viral proteases.
    DasGupta BR
    J Gen Appl Microbiol; 2006 Feb; 52(1):1-8. PubMed ID: 16598153
    [No Abstract]   [Full Text] [Related]  

  • 2. Responses of Clostridium botulinum type B and E progenitor toxins to some clostridial sulfhydryl-dependent proteases.
    Oishi I; Okada T; Sakaguchi G
    Jpn J Med Sci Biol; 1975 Jun; 28(3):157-64. PubMed ID: 1104932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quaternary structure of botulinum and tetanus neurotoxins as probed by chemical cross-linking and native gel electrophoresis.
    Ledoux DN; Be XH; Singh BR
    Toxicon; 1994 Sep; 32(9):1095-104. PubMed ID: 7801345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum neurotoxin detection and differentiation by mass spectrometry.
    Barr JR; Moura H; Boyer AE; Woolfitt AR; Kalb SR; Pavlopoulos A; McWilliams LG; Schmidt JG; Martinez RA; Ashley DL
    Emerg Infect Dis; 2005 Oct; 11(10):1578-83. PubMed ID: 16318699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Elements To Consider When Modeling the Hazards Associated with Botulinum Neurotoxin in Food.
    Ihekwaba AE; Mura I; Malakar PK; Walshaw J; Peck MW; Barker GC
    J Bacteriol; 2016 Jan; 198(2):204-11. PubMed ID: 26350137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of Clostridium botulinum toxins.
    Oguma K; Fujinaga Y; Inoue K
    Microbiol Immunol; 1995; 39(3):161-8. PubMed ID: 7603360
    [No Abstract]   [Full Text] [Related]  

  • 7. Beneficial and harmful roles of bacteria from the Clostridium genus.
    Samul D; Worsztynowicz P; Leja K; Grajek W
    Acta Biochim Pol; 2013; 60(4):515-21. PubMed ID: 24432307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based drug discovery for botulinum neurotoxins.
    Swaminathan S
    Curr Top Microbiol Immunol; 2013; 364():197-218. PubMed ID: 23239355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and biological activity of botulinum neurotoxin.
    DasGupta BR
    J Physiol (Paris); 1990; 84(3):220-8. PubMed ID: 2074545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum neurotoxins are zinc proteins.
    Schiavo G; Rossetto O; Santucci A; DasGupta BR; Montecucco C
    J Biol Chem; 1992 Nov; 267(33):23479-83. PubMed ID: 1429690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, Function and Evolution of Clostridium botulinum C2 and C3 Toxins: Insight to Poultry and Veterinary Vaccines.
    Chellapandi P; Prisilla A
    Curr Protein Pept Sci; 2017; 18(5):412-424. PubMed ID: 27915984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum versus tetanus neurotoxins: why is botulinum neurotoxin but not tetanus neurotoxin a food poison?
    Singh BR; Li B; Read D
    Toxicon; 1995 Dec; 33(12):1541-7. PubMed ID: 8866611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of Clostridium botulinum neurotoxin in chronic disease of dairy cows.
    Seyboldt C; Discher S; Jordan E; Neubauer H; Jensen KC; Campe A; Kreienbrock L; Scheu T; Wichern A; Gundling F; DoDuc P; Fohler S; Abdulmawjood A; Klein G; Hoedemaker M
    Vet Microbiol; 2015 Jun; 177(3-4):398-402. PubMed ID: 25882532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergency of nicking of the toxin from the proteolytic activity of Clostridium botulinum of different types.
    Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1979 Apr; 32(2):130-2. PubMed ID: 396397
    [No Abstract]   [Full Text] [Related]  

  • 15. Uptake of botulinum neurotoxin in the intestine.
    Fujinaga Y; Sugawara Y; Matsumura T
    Curr Top Microbiol Immunol; 2013; 364():45-59. PubMed ID: 23239348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-over inhibitor of the botulinum neurotoxin light chain B: a natural product implicating an exosite mechanism of action.
    Salzameda NT; Eubanks LM; Zakhari JS; Tsuchikama K; DeNunzio NJ; Allen KN; Hixon MS; Janda KD
    Chem Commun (Camb); 2011 Feb; 47(6):1713-5. PubMed ID: 21203627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation.
    Kumaran D; Eswaramoorthy S; Furey W; Navaza J; Sax M; Swaminathan S
    J Mol Biol; 2009 Feb; 386(1):233-45. PubMed ID: 19118561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a protease from Clostridium botulinum type A that nicks single-chain type A botulinum neurotoxin into the di-chain form.
    Dekleva ML; Dasgupta BR
    J Bacteriol; 1990 May; 172(5):2498-503. PubMed ID: 2185224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel.
    Koriazova LK; Montal M
    Nat Struct Biol; 2003 Jan; 10(1):13-8. PubMed ID: 12459720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexity of botulinum neurotoxins: challenges for detection technology.
    Dorner MB; Schulz KM; Kull S; Dorner BG
    Curr Top Microbiol Immunol; 2013; 364():219-55. PubMed ID: 23239356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.